Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2018 Mar 3

PMID 29495500

Citations 26

Authors

Sergio Lamprecht

Ina Sigal-Batikoff

Shraga Shany

Naim Abu-Freha

Eduard Ling

George J Delinasios

Keren Moyal-Atias

John G Delinasios

Alexander Fich

Affiliations

Soon will be listed here.

Abstract

It is well recognized that cancer cells subvert the phenotype of stromal naïve fibroblasts and instruct the neighboring cells to sustain their growth agenda. The mechanisms underpinning the switch of fibroblasts to cancer-associated fibroblasts (CAFs) are the focus of intense investigation. One of the most significant hallmarks of the biological identity of CAFs is that their tumor-promoting phenotype is stably maintained during in vitro and ex vivo propagation without the continual interaction with the adjacent cancer cells. In this review, we discuss robust evidence showing that the master cytokine Transforming Growth Factor-β1 (TGFβ-1) is a prime mover in reshaping, via epigenetic switches, the phenotype of stromal fibroblasts to a durable state. We also examine, in detail, the pervasive involvement of TGFβ-1 signaling from both cancer cells and CAFs in fostering cancer development, taking colorectal cancer (CRC) as a paradigm of human neoplasia. Finally, we review the stroma-centric anticancer therapeutic approach focused on CAFs-the most abundant cell population of the tumor microenvironment (TME)-as target cells.

Citing Articles

Design, Synthesis, and Biological Evaluation of a Novel [F]AlF-HRESCA-FAPI Radiotracer Targeting Fibroblast Activation Protein.

Zhang Q, Hu Z, Zhao H, Du F, Lv C, Peng T Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006089 PMC: 11859916. DOI: 10.3390/ph18020277.

The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis.

Yu S, Wang S, Wang X, Xu X Cancer Cell Int. 2024; 24(1):335.

PMID: 39375726 PMC: 11459962. DOI: 10.1186/s12935-024-03518-8.

Crosstalk between CAFs and tumour cells in head and neck cancer.

Li X, Gonzalez-Maroto C, Tavassoli M Cell Death Discov. 2024; 10(1):303.

PMID: 38926351 PMC: 11208506. DOI: 10.1038/s41420-024-02053-9.

AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B Oncogene. 2024; 43(27):2092-2103.

PMID: 38769192 PMC: 11702291. DOI: 10.1038/s41388-024-03064-7.

Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry.

Rogenes H, Finne K, Winge I, Akslen L, Ostman A, Milosevic V Front Immunol. 2024; 15:1325191.

PMID: 38711512 PMC: 11070582. DOI: 10.3389/fimmu.2024.1325191.

References

Pan X, Chen Z, Huang R, Yao Y, Ma G . Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts. PLoS One. 2013; 8(4):e60335. PMC: 3613378. DOI: 10.1371/journal.pone.0060335. View

Fukino K, Shen L, Matsumoto S, Morrison C, Mutter G, Eng C . Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 2004; 64(20):7231-6. DOI: 10.1158/0008-5472.CAN-04-2866. View

Paulsson J, Micke P . Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014; 25:61-8. DOI: 10.1016/j.semcancer.2014.02.006. View

Parat M . The biology of caveolae: achievements and perspectives. Int Rev Cell Mol Biol. 2009; 273:117-62. DOI: 10.1016/S1937-6448(08)01804-2. View

Sun Y . Tumor microenvironment and cancer therapy resistance. Cancer Lett. 2015; 380(1):205-15. DOI: 10.1016/j.canlet.2015.07.044. View

Tauriello D, Batlle E . Targeting the Microenvironment in Advanced Colorectal Cancer. Trends Cancer. 2017; 2(9):495-504. DOI: 10.1016/j.trecan.2016.08.001. View

Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

Liu T, Zhao M, Liu J, He Z, Zhang Y, You H . Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses. Oncogene. 2016; 36(3):362-372. PMC: 5140778. DOI: 10.1038/onc.2016.204. View

Vicent S, Sayles L, Vaka D, Khatri P, Gevaert O, Chen R . Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res. 2012; 72(22):5744-56. PMC: 3856949. DOI: 10.1158/0008-5472.CAN-12-1097. View

10.

Kalluri R . The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016; 16(9):582-98. DOI: 10.1038/nrc.2016.73. View

11.

Seoane J, Gomis R . TGF-β Family Signaling in Tumor Suppression and Cancer Progression. Cold Spring Harb Perspect Biol. 2017; 9(12). PMC: 5710110. DOI: 10.1101/cshperspect.a022277. View

12.

Tape C . The Heterocellular Emergence of Colorectal Cancer. Trends Cancer. 2017; 3(2):79-88. PMC: 5312168. DOI: 10.1016/j.trecan.2016.12.004. View

13.

Whatcott C, Han H, Von Hoff D . Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction. Cancer J. 2015; 21(4):299-306. PMC: 4817719. DOI: 10.1097/PPO.0000000000000140. View

14.

Akhurst R, Hata A . Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 2012; 11(10):790-811. PMC: 3520610. DOI: 10.1038/nrd3810. View

15.

Polanska U, Orimo A . Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol. 2013; 228(8):1651-7. DOI: 10.1002/jcp.24347. View

16.

McMillin D, Negri J, Mitsiades C . The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov. 2013; 12(3):217-28. DOI: 10.1038/nrd3870. View

17.

Rizzi C, Cataldi P, Iop A, Isola M, Sgarra R, Manfioletti G . The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness. Hum Pathol. 2012; 44(1):122-32. DOI: 10.1016/j.humpath.2012.05.001. View

18.

Kurose K, Gilley K, Matsumoto S, Watson P, Zhou X, Eng C . Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet. 2002; 32(3):355-7. DOI: 10.1038/ng1013. View

19.

Grady W, Rajput A, Myeroff L, Liu D, Kwon K, Willis J . Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 1998; 58(14):3101-4. View

20.

DeClerck Y, Pienta K, Woodhouse E, Singer D, Mohla S . The Tumor Microenvironment at a Turning Point Knowledge Gained Over the Last Decade, and Challenges and Opportunities Ahead: A White Paper from the NCI TME Network. Cancer Res. 2017; 77(5):1051-1059. PMC: 5719879. DOI: 10.1158/0008-5472.CAN-16-1336. View